Agilent and National Heart Centre Singapore Sign Agreement to Advance Metabolic Heart Failure Research
November 13, 2025
November 13, 2025
SANTA CLARA, California, Nov. 13 [Category: BizLaboratory Sciences] -- Agilent Technologies, a company that specializes in life sciences, diagnostics and applied chemical markets, issued the following news release:
* * *
Agilent and National Heart Centre Singapore Sign Agreement to Advance Metabolic Heart Failure Research
*
Agilent Technologies Inc. (NYSE: A) announced the signing of a five-year Memorandum of Understanding (MOU) with National H . . .
* * *
Agilent and National Heart Centre Singapore Sign Agreement to Advance Metabolic Heart Failure Research
*
Agilent Technologies Inc. (NYSE: A) announced the signing of a five-year Memorandum of Understanding (MOU) with National H . . .
